Skip to main content
. 2018 Mar 23;9(22):15942–15951. doi: 10.18632/oncotarget.24639

Table 1. Immunohistochemical analysis of BATF3 expression.

Entity BATF3-positive cases/total cases (%)
DLBCL 11/21 (52)
HL 12/12 (100)
ALCL 14/18 (78)